Ryan G. Aleong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ryan G. Aleong has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Paul D. Varosy
10 shared publications- Wendy S. Tzou
Cardiac Electrophysiology Section, Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
8 shared publications - Duy Thai Nguyen
Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine Stanford University Stanford California USA
7 shared publications - Matthew M. Zipse
University of Colorado Anschutz Medical Campus
7 shared publications William H. Sauer
University of Colorado, Denver, CO
7 shared publications- William H. Sauer
Section of Cardiac Electrophysiology, Division of Cardiology, University of Colorado, Aurora, Colorado
7 shared publications
Latest Publications
- Open Access
- 9 August 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (10) , 698-704
Ventricular stimulation in patients with myotonic dystrophy type 1 may not predict future ventricular arrhythmias
- 9 August 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (10) , 698-704
Open AccessVentricular stimulation in patients with myotonic dystrophy type 1 may not predict future ventricular arrhythmias
- Open Access
- 1 August 2024
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 15 (08) , 5985-5989
Feasibility of Single-lead Cardiac Resynchronization and Defibrillation Therapy in an Animal Model
Feasibility of Single-lead Cardiac Resynchronization and Defibrillation Therapy in an Animal Model
- 1 August 2024
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 15 (08) , 5985-5989
Open AccessFeasibility of Single-lead Cardiac Resynchronization and Defibrillation Therapy in an Animal Model
Feasibility of Single-lead Cardiac Resynchronization and Defibrillation Therapy in an Animal Model
- Open Access
- 24 November 2023
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 10 (2) , 142-145
Atrial isochronal late activation mapping keeps the diaphragm alive
- 24 November 2023
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 10 (2) , 142-145
Open AccessAtrial isochronal late activation mapping keeps the diaphragm alive
- Open Access
- 1 January 2023
- Published by Knowledge Enterprise Journals in Medical Research Archives
- Vol. 11 (10)
A Discussion of the Contemporary Prediction Models for Atrial Fibrillation
Atrial Fibrillation is a complex disease state with many environmental and genetic risk factors. While there are environmental factors that have been shown to increase an individual’s risk of atrial fibrillation, it has become clear that atrial fibrillation has a genetic component that influences why some patients are at a higher risk of developing atrial fibrillation compared to others. This review will first discuss the clinical diagnosis of atrial fibrillation and the corresponding rhythm atrial flutter. We will then discuss how a patients’ risk of stroke can be assessed by using other clinical co-morbidities. We will then review the clinical risk factors that can be used to help predict an individual patient’s risk of atrial fibrillation. Many of the clinical risk factors have been used to create several different risk scoring methods that will be reviewed. We will then discuss how genetics can be used to identify individuals who are at higher risk for developing atrial fibrillation. We will discuss genome-wide association studies and other sequencing high-throughput sequencing studies. Finally, we will touch on how genetic variants derived from a genome-wide association studies can be used to calculate an individual’s polygenic risk score for atrial fibrillation. An atrial fibrillation polygenic risk score can be used to identify patients at higher risk of developing atrial fibrillation and may allow for a reduction in some of the complications associated with atrial fibrillation such as cerebrovascular accidents and the development of heart failure. Finally, there is a brief discussion of how artificial intelligence models can be used to predict which patients will develop atrial fibrillation.
- 1 January 2023
- Published by Knowledge Enterprise Journals in Medical Research Archives
- Vol. 11 (10)
Open AccessA Discussion of the Contemporary Prediction Models for Atrial Fibrillation
Atrial Fibrillation is a complex disease state with many environmental and genetic risk factors. While there are environmental factors that have been shown to increase an individual’s risk of atrial fibrillation, it has become clear that atrial fibrillation has a genetic component that influences why some patients are at a higher risk of developing atrial fibrillation compared to others. This review will first discuss the clinical diagnosis of atrial fibrillation and the corresponding rhythm atrial flutter. We will then discuss how a patients’ risk of stroke can be assessed by using other clinical co-morbidities. We will then review the clinical risk factors that can be used to help predict an individual patient’s risk of atrial fibrillation. Many of the clinical risk factors have been used to create several different risk scoring methods that will be reviewed. We will then discuss how genetics can be used to identify individuals who are at higher risk for developing atrial fibrillation. We will discuss genome-wide association studies and other sequencing high-throughput sequencing studies. Finally, we will touch on how genetic variants derived from a genome-wide association studies can be used to calculate an individual’s polygenic risk score for atrial fibrillation. An atrial fibrillation polygenic risk score can be used to identify patients at higher risk of developing atrial fibrillation and may allow for a reduction in some of the complications associated with atrial fibrillation such as cerebrovascular accidents and the development of heart failure. Finally, there is a brief discussion of how artificial intelligence models can be used to predict which patients will develop atrial fibrillation.
- Open Access
- 21 September 2022
- Published by Elsevier in JACC: Case Reports
- Vol. 4 (18) , 1180-1185
Esophago-Pericardial Fistula as a Rare and Life-Threatening Complication of Epicardial Ventricular Tachycardia Ablation
- 21 September 2022
- Published by Elsevier in JACC: Case Reports
- Vol. 4 (18) , 1180-1185
Open AccessEsophago-Pericardial Fistula as a Rare and Life-Threatening Complication of Epicardial Ventricular Tachycardia Ablation
- Open Access
- 6 December 2021
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 9 (12) , e29225
Machine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study
Background: The identification of an appropriate rhythm management strategy for patients diagnosed with atrial fibrillation (AF) remains a major challenge for providers. Although clinical trials have identified subgroups of patients in whom a rate- or rhythm-control strategy might be indicated to improve outcomes, the wide range of presentations and risk factors among patients presenting with AF makes such approaches challenging. The strength of electronic health records is the ability to build in logic to guide management decisions, such that the system can automatically identify patients in whom a rhythm-control strategy is more likely and can promote efficient referrals to specialists. However, like any clinical decision support tool, there is a balance between interpretability and accurate prediction. Objective: This study aims to create an electronic health record–based prediction tool to guide patient referral to specialists for rhythm-control management by comparing different machine learning algorithms. Methods: We compared machine learning models of increasing complexity and used up to 50,845 variables to predict the rhythm-control strategy in 42,022 patients within the University of Colorado Health system at the time of AF diagnosis. Models were evaluated on the basis of their classification accuracy, defined by the F1 score and other metrics, and interpretability, captured by inspection of the relative importance of each predictor. Results: We found that age was by far the strongest single predictor of a rhythm-control strategy but that greater accuracy could be achieved with more complex models incorporating neural networks and more predictors for each participant. We determined that the impact of better prediction models was notable primarily in the rate of inappropriate referrals for rhythm-control, in which more complex models provided an average of 20% fewer inappropriate referrals than simpler, more interpretable models. Conclusions: We conclude that any health care system seeking to incorporate algorithms to guide rhythm management for patients with AF will need to address this trade-off between prediction accuracy and model interpretability.
- 6 December 2021
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 9 (12) , e29225
Open AccessMachine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study
Background: The identification of an appropriate rhythm management strategy for patients diagnosed with atrial fibrillation (AF) remains a major challenge for providers. Although clinical trials have identified subgroups of patients in whom a rate- or rhythm-control strategy might be indicated to improve outcomes, the wide range of presentations and risk factors among patients presenting with AF makes such approaches challenging. The strength of electronic health records is the ability to build in logic to guide management decisions, such that the system can automatically identify patients in whom a rhythm-control strategy is more likely and can promote efficient referrals to specialists. However, like any clinical decision support tool, there is a balance between interpretability and accurate prediction. Objective: This study aims to create an electronic health record–based prediction tool to guide patient referral to specialists for rhythm-control management by comparing different machine learning algorithms. Methods: We compared machine learning models of increasing complexity and used up to 50,845 variables to predict the rhythm-control strategy in 42,022 patients within the University of Colorado Health system at the time of AF diagnosis. Models were evaluated on the basis of their classification accuracy, defined by the F1 score and other metrics, and interpretability, captured by inspection of the relative importance of each predictor. Results: We found that age was by far the strongest single predictor of a rhythm-control strategy but that greater accuracy could be achieved with more complex models incorporating neural networks and more predictors for each participant. We determined that the impact of better prediction models was notable primarily in the rate of inappropriate referrals for rhythm-control, in which more complex models provided an average of 20% fewer inappropriate referrals than simpler, more interpretable models. Conclusions: We conclude that any health care system seeking to incorporate algorithms to guide rhythm management for patients with AF will need to address this trade-off between prediction accuracy and model interpretability.
- 1 August 2021
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (8)
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype
Background: Bucindolol is a genetically targeted β-blocker/mild vasodilator with the unique pharmacological properties of sympatholysis and ADRB1 Arg389 receptor inverse agonism. In the GENETIC-AF trial (Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for the Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure) conducted in a genetically defined heart failure population at high risk for recurrent atrial fibrillation (AF), similar results were observed for bucindolol and metoprolol succinate for the primary end point of time to first AF event; however, AF burden and other rhythm control measures were not analyzed. Methods: The prevalence of ECGs in normal sinus rhythm, AF interventions for rhythm control (cardioversion, ablation, and antiarrhythmic drugs) and biomarkers were evaluated in the overall population entering efficacy follow-up (N=257). AF burden was evaluated for 24 weeks in the device substudy (N=67). Results: In 257 patients with heart failure, the mean age was 65.6±10.0 years, 18% were female, mean left ventricular ejection fraction was 36%, and 51% had persistent AF. Cumulative 24-week AF burden was 24.4% (95% CI, 18.5–30.2) for bucindolol and 36.7% (95% CI, 30.0–43.5) for metoprolol (33% reduction, P P P P =0.011). Reductions in plasma norepinephrine ( P =0.038) and NT-proBNP (N-terminal pro B-type natriuretic peptide; P =0.009) were also observed with bucindolol compared with metoprolol. Conclusions: Compared with metoprolol, bucindolol reduced AF burden, improved maintenance of sinus rhythm, and lowered the need for additional rhythm control interventions in patients with heart failure and the ADRB1 Arg389Arg genotype. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01970501.
- 1 August 2021
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (8)
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype
Background: Bucindolol is a genetically targeted β-blocker/mild vasodilator with the unique pharmacological properties of sympatholysis and ADRB1 Arg389 receptor inverse agonism. In the GENETIC-AF trial (Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for the Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure) conducted in a genetically defined heart failure population at high risk for recurrent atrial fibrillation (AF), similar results were observed for bucindolol and metoprolol succinate for the primary end point of time to first AF event; however, AF burden and other rhythm control measures were not analyzed. Methods: The prevalence of ECGs in normal sinus rhythm, AF interventions for rhythm control (cardioversion, ablation, and antiarrhythmic drugs) and biomarkers were evaluated in the overall population entering efficacy follow-up (N=257). AF burden was evaluated for 24 weeks in the device substudy (N=67). Results: In 257 patients with heart failure, the mean age was 65.6±10.0 years, 18% were female, mean left ventricular ejection fraction was 36%, and 51% had persistent AF. Cumulative 24-week AF burden was 24.4% (95% CI, 18.5–30.2) for bucindolol and 36.7% (95% CI, 30.0–43.5) for metoprolol (33% reduction, P P P P =0.011). Reductions in plasma norepinephrine ( P =0.038) and NT-proBNP (N-terminal pro B-type natriuretic peptide; P =0.009) were also observed with bucindolol compared with metoprolol. Conclusions: Compared with metoprolol, bucindolol reduced AF burden, improved maintenance of sinus rhythm, and lowered the need for additional rhythm control interventions in patients with heart failure and the ADRB1 Arg389Arg genotype. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01970501.
- 1 August 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , S118
B-PO02-055 REPEATED LEAD DISLODGEMENT - A SIGN OF BREWING CANDIDA INFECTION
- 1 August 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , S118
B-PO02-055 REPEATED LEAD DISLODGEMENT - A SIGN OF BREWING CANDIDA INFECTION
- Open Access
- 30 March 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Machine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study (Preprint)
BACKGROUND The identification of an appropriate rhythm management strategy for patients diagnosed with atrial fibrillation (AF) remains a major challenge for providers. Although clinical trials have identified subgroups of patients in whom a rate- or rhythm-control strategy might be indicated to improve outcomes, the wide range of presentations and risk factors among patients presenting with AF makes such approaches challenging. The strength of electronic health records is the ability to build in logic to guide management decisions, such that the system can automatically identify patients in whom a rhythm-control strategy is more likely and can promote efficient referrals to specialists. However, like any clinical decision support tool, there is a balance between interpretability and accurate prediction. OBJECTIVE This study aims to create an electronic health record–based prediction tool to guide patient referral to specialists for rhythm-control management by comparing different machine learning algorithms. METHODS We compared machine learning models of increasing complexity and used up to 50,845 variables to predict the rhythm-control strategy in 42,022 patients within the University of Colorado Health system at the time of AF diagnosis. Models were evaluated on the basis of their classification accuracy, defined by the F1 score and other metrics, and interpretability, captured by inspection of the relative importance of each predictor. RESULTS We found that age was by far the strongest single predictor of a rhythm-control strategy but that greater accuracy could be achieved with more complex models incorporating neural networks and more predictors for each participant. We determined that the impact of better prediction models was notable primarily in the rate of inappropriate referrals for rhythm-control, in which more complex models provided an average of 20% fewer inappropriate referrals than simpler, more interpretable models. CONCLUSIONS We conclude that any health care system seeking to incorporate algorithms to guide rhythm management for patients with AF will need to address this trade-off between prediction accuracy and model interpretability.
- 30 March 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMachine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study (Preprint)
BACKGROUND The identification of an appropriate rhythm management strategy for patients diagnosed with atrial fibrillation (AF) remains a major challenge for providers. Although clinical trials have identified subgroups of patients in whom a rate- or rhythm-control strategy might be indicated to improve outcomes, the wide range of presentations and risk factors among patients presenting with AF makes such approaches challenging. The strength of electronic health records is the ability to build in logic to guide management decisions, such that the system can automatically identify patients in whom a rhythm-control strategy is more likely and can promote efficient referrals to specialists. However, like any clinical decision support tool, there is a balance between interpretability and accurate prediction. OBJECTIVE This study aims to create an electronic health record–based prediction tool to guide patient referral to specialists for rhythm-control management by comparing different machine learning algorithms. METHODS We compared machine learning models of increasing complexity and used up to 50,845 variables to predict the rhythm-control strategy in 42,022 patients within the University of Colorado Health system at the time of AF diagnosis. Models were evaluated on the basis of their classification accuracy, defined by the F1 score and other metrics, and interpretability, captured by inspection of the relative importance of each predictor. RESULTS We found that age was by far the strongest single predictor of a rhythm-control strategy but that greater accuracy could be achieved with more complex models incorporating neural networks and more predictors for each participant. We determined that the impact of better prediction models was notable primarily in the rate of inappropriate referrals for rhythm-control, in which more complex models provided an average of 20% fewer inappropriate referrals than simpler, more interpretable models. CONCLUSIONS We conclude that any health care system seeking to incorporate algorithms to guide rhythm management for patients with AF will need to address this trade-off between prediction accuracy and model interpretability.
- Open Access
- 4 November 2020
- Published by Wiley
Outcomes of Left Atrial Ablation in Patients with Prior Mitral Valve Surgery
Background: Patients with a history of mitral valve (MV) surgery can present with unique challenges during left atrial (LA) ablation due to abnormal atrial substrate and descriptions of ablation in this cohort is limited. We aim to evaluate LA ablation characteristics and outcomes in patients with a history of mitral valve surgery. Objective: We hypothesize that the success rate for ablations of LA arrhythmias in patients with prior MV surgery will be inferior to patients without prior MV surgery due to left atriopathy, presence of a MV prosthesis, and a higher burden of pre-ablation LA scar. Methods: In this single center, retrospective study, we evaluated patients who had a history of MV surgery and underwent LA ablation between January 2013 and May 2019. We analyzed baseline patient characteristics, type of MV disease and surgery, available pre-ablation voltage maps, and ablation outcomes. Results: We present a series of 20 patients who underwent a total of 30 LA ablation procedures. All 20 patients underwent pulmonary vein isolation and 11 patients also underwent ablation for LA macro-reentrant flutters. The majority of the patients (55%) were without recurrent documented arrhythmias at a mean follow-up of 22 months post-ablation. Two patients had acutely unsuccessful ablation. Conclusions: Although LA ablation in patients with previous MV surgery can be challenging due to abnormal atrial substrate and the presence of the valve prosthesis, the majority of patients in our cohort experienced atrial arrhythmia free survival at a mean follow-up of 22 months.
- 4 November 2020
- Published by Wiley
Open AccessOutcomes of Left Atrial Ablation in Patients with Prior Mitral Valve Surgery
Background: Patients with a history of mitral valve (MV) surgery can present with unique challenges during left atrial (LA) ablation due to abnormal atrial substrate and descriptions of ablation in this cohort is limited. We aim to evaluate LA ablation characteristics and outcomes in patients with a history of mitral valve surgery. Objective: We hypothesize that the success rate for ablations of LA arrhythmias in patients with prior MV surgery will be inferior to patients without prior MV surgery due to left atriopathy, presence of a MV prosthesis, and a higher burden of pre-ablation LA scar. Methods: In this single center, retrospective study, we evaluated patients who had a history of MV surgery and underwent LA ablation between January 2013 and May 2019. We analyzed baseline patient characteristics, type of MV disease and surgery, available pre-ablation voltage maps, and ablation outcomes. Results: We present a series of 20 patients who underwent a total of 30 LA ablation procedures. All 20 patients underwent pulmonary vein isolation and 11 patients also underwent ablation for LA macro-reentrant flutters. The majority of the patients (55%) were without recurrent documented arrhythmias at a mean follow-up of 22 months post-ablation. Two patients had acutely unsuccessful ablation. Conclusions: Although LA ablation in patients with previous MV surgery can be challenging due to abnormal atrial substrate and the presence of the valve prosthesis, the majority of patients in our cohort experienced atrial arrhythmia free survival at a mean follow-up of 22 months.